×
Fulgent Genetics Receivables 2015-2024 | FLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Fulgent Genetics receivables from 2015 to 2024. Receivables can be defined as the total amount of collectibles for a company
Quarterly Chart
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.2B
Hims & Hers Health (HIMS)
$15B
Tempus AI (TEM)
$13.5B
Inspire Medical Systems (INSP)
$5.3B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$3.1B
Enovis (ENOV)
$2.5B
Clover Health Investments (CLOV)
$2.3B
Azenta (AZTA)
$2.1B
Schrodinger (SDGR)
$1.9B
Omnicell (OMCL)
$1.9B
Phreesia (PHR)
$1.7B
10x Genomics (TXG)
$1.5B
Butterfly Network (BFLY)
$1B
Talkspace (TALK)
$652M
Standard BioTools (LAB)
$517M
TruBridge (TBRG)
$426M
Nyxoah SA (NYXH)
$357M
Health Catalyst (HCAT)
$338M
SOPHiA GENETICS SA (SOPH)
$319M
Pulmonx (LUNG)
$262M
American Well (AMWL)
$191M
EUDA Health Holdings (EUDA)
$102M
MDxHealth SA (MDXH)
$88M
P3 Health Partners (PIII)
$77M
111 (YI)
$69M
CareCloud (CCLD)
$63M
HeartBeam (BEAT)
$58M
Outset Medical (OM)
$50M
Zepp Health (ZEPP)
$45M